Company type | Private |
---|---|
Industry | Biotech |
Founded | Singapore (2010), Germany (2012) |
Founder | Andreas Schmidt, Dieter Trau |
Headquarters | Cologne , Germany |
Key people | Albrecht Läufer (CEO), Markus Zumbansen (CTO) |
Products | Development of a Protein chip platform based on the Bead-based Arrays, named LUNARIS (TM) multiplexing technology |
Production output | Biomarker Detection Kits |
Services | Multiplexing and Readout Services, Assay Development Services |
Owner | Prosnav Capital, and others |
Subsidiaries | Ayoxxa Inc. (USA), Ayoxxa Living Health Technologies Pte. Ltd (Singapore) |
Website | www |
Ayoxxa Biosystems (stylized in its logo as AYOXXA) is a biotechnology company founded in 2010 in Singapore, and headquartered in Germany.[1][2]
The company is known for developing protein chip capable of detecting at once multiple biomarkers, biomarker signatures (including markers for cancer, allergies, age related macular degeneration AMD, or infectious diseases) from a small biological sample. The protein chip yields large amounts of data, being primarily aimed for use in biomedical research in academia, clinic and industry.[1][3][4][5][6]
Tan 2012
was invoked but never defined (see the help page).Chng January 2013
was invoked but never defined (see the help page).Ramchandani 2013
was invoked but never defined (see the help page).Moran 2012
was invoked but never defined (see the help page).Greve 2014
was invoked but never defined (see the help page).Lim 2012
was invoked but never defined (see the help page).